Simple blood test could reveal epilepsy risk

February 12, 2018 by Gary Finnegan, From Horizon Magazine, Horizon: The EU Research & Innovation Magazine
It is difficult for doctors to diagnose epilepsy as they usually do not observe the symptoms in a patient, but a blood test could overcome this challenge. Credit: picture is in public domain

A finger-prick blood test to diagnose epilepsy could be available within five years, according to scientists who are using tell-tale molecules called biomarkers to overcome current diagnostic problems and guide treatment.

More than 50 million people are affected by epilepsy worldwide. However, diagnosing the disease remains challenging and treatments are often unsuccessful: only 70% of patients taking anti-epileptic drugs are -free.

"Diagnosis of is really difficult," explained David Henshall, professor of molecular physiology and neuroscience at the Royal College of Surgeons in Ireland. "Seizures are the main clinical symptom for the disease but it is very rare that a doctor will witness the patient having a seizure. This makes epilepsy completely different from Parkinson's disease, for example, where the doctor can observe the symptoms."

One of the most common tests for epilepsy is an electroencephalogram (EEG), which detects abnormal electrical activity in the brain. "The problem is that a lot of people with epilepsy have normal EEGs, while others may have abnormal EEGs but do not have epilepsy," said Prof. Henshall. "That's why we need a better test."

An ideal solution would be a simple blood test that detects biomarkers – the tell-tale molecular signs that someone has epilepsy. Prof. Henshall leads the EPIMIRNA consortium which has been studying micro RNA (miRNA) – micro ribonucleic acid, molecules which can influence genes – to see if these could be the key to diagnosing epilepsy.

By comparing the levels of several miRNA molecules in the blood of healthy volunteers with levels in epilepsy patients, the researchers can see which ones are associated with epilepsy.

"We have identified a set of miRNAs that are consistently changed in the blood levels of people with epilepsy," Prof Henshall said.

Seizures

One of the promising applications of this finding will be in helping doctors to distinguish between patients with epilepsy and those who have seizures for other reasons. "There is a challenging group of patients who have non-epileptic seizures or psychogenic attacks (seizures of psychological origin)," he said.

"These patients are often put on for long periods before it is realised that they do not have epilepsy. We found that (people in that) group have normal levels of epilepsy-related miRNAs – it's one of our most valuable findings."

The group is now working with chemists to develop a prototype device that can detect low levels of these biomarkers in the blood. If successful, a finger-prick blood test, similar to a blood glucose test used in diabetes patients – could be available within five years.

Once diagnosed, the challenge becomes finding the right treatment. Not all are the same and a drug that works well in one patient might not prevent seizures in another. Many patients try several drugs before finding the one that best suits them.

However, by combining biomarkers and other tools – such as brain scans – researchers hope to help doctors choose the right treatment for the right patient every time.

"Single biomarkers have not been very successful (in guiding treatments) because epilepsy is a complex condition with multiple processes involved," said Merab Kokaia, professor of neurology at Lund University in Sweden. "Combinational biomarkers could improve diagnosis but also improve outcomes by beginning treatment earlier."

If doctors know which brain processes are involved in a patient's epilepsy, they can predict how the disease will develop and perhaps even stop it in its tracks.

Biomarkers

Prof. Kokaia leads the EPITARGET project which has identified biomarkers in the blood that could lead to more tailored treatments. These includes miRNAs and a protein known as HMGB1, amongst others.

One of the key areas of interest is the effect of trauma on the brain. People who have suffered traumatic brain injury are at higher risk of developing epilepsy, but only 20-25% actually develop the condition. Before a patient begins to suffer epileptic seizures, several changes in the brain take place. This gradual process, known as epileptogenesis, could be arrested through early treatment.

"Using selective and specific reliable biomarkers, we want to identify at risk so that we can treat them and perhaps prevent the development of epilepsy," said Prof. Kokaia. "We have shown that this is possible in animals and will test it in humans."

Identifying biomarkers and changes to brain structures may ultimately lead to new treatments that target the molecules shown to be active in epilepsy. "Combining biomarkers is key," said Prof Kokaia. "It could make more personalised in the years to come."

All research in this article is funded by the EU. The key findings from these and other epilepsy research projects will be presented at the epiXchange conference in Brussels, Belgium on 23 May.

The Issue

Approximately 6 million people in Europe suffer from epilepsy, a chronic brain disorder that is characterised by recurrent seizures. It affects people of all ages.

Over the last decade the EU allocated around €176 million in funding for research into dianostic tools and therapeutic interventions for epilepsy.

In 2011, the European Parliament submitted a written declaration on epilepsy which led to the 2015 establishment of the European Reference Network for the care of individuals with rare and complex epilepsies.

Explore further: Brain waves may predict and potentially prevent epilepsy

Related Stories

Brain waves may predict and potentially prevent epilepsy

December 21, 2017
Ben-Gurion University of the Negev (BGU) researchers have discovered a promising biomarker for predicting and potentially preventing epileptic seizures in patients with brain injuries using EEG (electroencephalographic) recordings ...

Epileptic seizures and depression may share a common genetic cause, study suggests

January 10, 2018
From the time of Hippocrates, physicians have suspected a link between epilepsy and depression. Now, for the first time, scientists at Rutgers University-New Brunswick and Columbia University have found evidence that seizures ...

Researchers identify treatment for drug-resistant epilepsy

June 29, 2016
New research into the treatment of epilepsy, led by scientists at RCSI (Royal College of Surgeons in Ireland), has identified a new approach to drug therapy to prevent seizures in patients who have a drug-resistant form of ...

Treatments available for drug-resistant epilepsy

August 22, 2016
One in 26 people will develop epilepsy – a chronic disease characterized by unpredictable seizures—in their lifetime.

Some psychotic disorders may be induced by drugs designed to combat effects of epilepsy

August 9, 2016
Today Brain publishes a new study indicating that antiepileptic drugs designed to reduce seizures, may also induce psychotic disorders in some patients.

11 percent of stroke survivors struggle with epilepsy

December 5, 2016
(HealthDay)—More than one in 10 stroke survivors develop epilepsy, and the greater the brain damage caused by stroke, the higher the risk of seizures, a new study reports.

Recommended for you

Precision neuroengineering enables reproduction of complex brain-like functions in vitro

November 14, 2018
One of the most important and surprising traits of the brain is its ability to dynamically reconfigure the connections to process and respond properly to stimuli. Researchers from Tohoku University (Sendai, Japan) and the ...

A 15-minute scan could help diagnose brain damage in newborns

November 14, 2018
A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods.

New brain imaging research shows that when we expect something to hurt it does, even if the stimulus isn't so painful

November 14, 2018
Expect a shot to hurt and it probably will, even if the needle poke isn't really so painful. Brace for a second shot and you'll likely flinch again, even though—second time around—you should know better.

New clues to the origin and progression of multiple sclerosis

November 13, 2018
Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The ...

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

In live brain function, researchers are finally seeing red

November 12, 2018
For years, green has been the most reliable hue for live brain imaging, but after using a new high-throughput screening method, researchers at the John B. Pierce Laboratory and the Yale School of Medicine, together with collaborators ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.